Back
JPMorgan Active Value ETF Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Buy
56
JAVA
JPMorgan Active Value ETF
Last Price:
$72.60
Seasonality Move:
3.28%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$32.10
Seasonality Move:
-6.94%
Buy
56
JPMorgan Active Value ETF (JAVA)
is a Buy
Is JPMorgan Active Value ETF a Buy, Sell or Hold?
-
The current JPMorgan Active Value ETF [JAVA] share price is $72.04. The Score for JAVA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
JAVA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $30.68. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JAVA Stock Price Chart
What is JPMorgan Active Value ETF's stock price today?
-
The JPMorgan Active Value ETF share price today is $72.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $30.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.68 | Buy |
| Relative Strength Index (14 RSI): | 64.3 | Buy |
| Chaikin Money Flow: | 223836 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.04 - 71.3) | Buy |
| Bollinger Bands (100): | (66.8 - 70.08) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.69 | Buy |
| Relative Strength Index (14 RSI): | 80.55 | Buy |
| Chaikin Money Flow: | 6400058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.73 - 28.39) | Buy |
| Bollinger Bands (100): | (3.38 - 17.56) | Buy |
JAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.34 | Buy |
| 20-day SMA: | 70.29 | Buy |
| 50-day SMA: | 69.6 | Buy |
| 200-day SMA: | 65.9 | Buy |
| 8-day EMA: | 71.27 | Buy |
| 20-day EMA: | 70.59 | Buy |
| 50-day EMA: | 68.17 | Buy |
| 200-day EMA: | 42 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Buy |
| 20-day SMA: | 22.38 | Buy |
| 50-day SMA: | 14.55 | Buy |
| 200-day SMA: | 7.46 | Buy |
| 8-day EMA: | 27.53 | Buy |
| 20-day EMA: | 23.23 | Buy |
| 50-day EMA: | 16.87 | Buy |
| 200-day EMA: | 9.95 | Buy |
JPMorgan Active Value ETF Earnings Growth & JAVA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and a decrease next year of $0.48 per share.
JPMorgan Active Value ETF Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||